BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Somma E, Jain RW, Poon KW, Tresidder KA, Segal JP, Ghasemlou N. Chronobiological regulation of psychosocial and physiological outcomes in multiple sclerosis. Neuroscience & Biobehavioral Reviews 2018;88:73-83. [DOI: 10.1016/j.neubiorev.2018.03.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Cisbani G, Poggini S, Laflamme N, Pons V, Tremblay MÈ, Branchi I, Rivest S. The Intellicage system provides a reproducible and standardized method to assess behavioral changes in cuprizone-induced demyelination mouse model. Behav Brain Res 2021;400:113039. [PMID: 33279637 DOI: 10.1016/j.bbr.2020.113039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches. Int J Mol Sci 2018;19:E1212. [PMID: 29659554 DOI: 10.3390/ijms19041212] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
3 Ursini F, De Giorgi A, D'Onghia M, De Giorgio R, Fabbian F, Manfredini R. Chronobiology and Chronotherapy in Inflammatory Joint Diseases. Pharmaceutics 2021;13:1832. [PMID: 34834246 DOI: 10.3390/pharmaceutics13111832] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bicker J, Fortuna A, Alves G, Falcão A. Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders. Curr Pharm Des 2020;26:594-619. [PMID: 31939728 DOI: 10.2174/1381612826666200115101544] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]